The alkalizer citrate reduces serum uric acid levels and improves renal function in hyperuricemic patients treated with the xanthine oxidase inhibitor allopurinol

Jun Saito, Yoko Matsuzawa, Hiroko Ito, Masao Omura, Yuzuru Ito, Koichiro Yoshimura, Yuki Yajima, Tomoshige Kino, Tetsuo Nishikawa

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective. Hyperuricemia, an integral component of metabolic syndrome, is a major health problem causing gout and renal damage. Urine alkalizers such as citrate preparations facilitate renal excretion of the uric acid, but its supportive effect on xanthine oxidase inhibitors has not been tested yet. We performed a randomized, prospective study of the effect of a combination of allopurinol and a citrate preparation on renal function in patients with hyperuricemia, employing 70 patients who had hyperuricemia with serum uric acid levels ≥7.0 mgdL, or those diagnosed as having hyperuricemia in the past. Methods. They were randomly enrolled into two study groups: the allopurinol monotherapy (MT) group or combination treatment (CT) group with allopurinol and a citrate preparation. Allopurinol (100200 mgday) in the absence or presence of a citrate preparation (3 gday) was administered for 12 weeks and levels of serum uric acid, its urinary clearance (Cua), and the renal glomerular filtration rates assessed with the creatinine clearance (Ccr) were evaluated before and after the treatment. Results. Serum levels of uric acid decreased significantly in both groups, whereas the change observed was much greater in CT group. Cua was significantly increased in CT group but not in MT group. Ccr was not altered in both groups in general, whereas it was significantly increased in a fraction of CT group with decreased renal function. Conclusions. These results indicate that an additional use of citrate preparations with xanthine oxidase inhibitors is beneficial for patients with hyperuricemia, reducing circulating uric acid and improving their glomerular filtration rates.

Original languageEnglish
Pages (from-to)145-154
Number of pages10
JournalEndocrine Research
Volume35
Issue number4
DOIs
Publication statusPublished - Nov 2010
Externally publishedYes

Fingerprint

Hyperuricemia
Allopurinol
Xanthine Oxidase
Uric Acid
Citric Acid
Kidney
Serum
Glomerular Filtration Rate
Creatinine
Therapeutics
Gout
Urine
Prospective Studies
Health

Keywords

  • Allopurinol
  • Citrate preparation
  • Creatinine clearance
  • Hyperuricemia
  • Renal function

ASJC Scopus subject areas

  • Endocrinology

Cite this

The alkalizer citrate reduces serum uric acid levels and improves renal function in hyperuricemic patients treated with the xanthine oxidase inhibitor allopurinol. / Saito, Jun; Matsuzawa, Yoko; Ito, Hiroko; Omura, Masao; Ito, Yuzuru; Yoshimura, Koichiro; Yajima, Yuki; Kino, Tomoshige; Nishikawa, Tetsuo.

In: Endocrine Research, Vol. 35, No. 4, 11.2010, p. 145-154.

Research output: Contribution to journalArticle

Saito, Jun ; Matsuzawa, Yoko ; Ito, Hiroko ; Omura, Masao ; Ito, Yuzuru ; Yoshimura, Koichiro ; Yajima, Yuki ; Kino, Tomoshige ; Nishikawa, Tetsuo. / The alkalizer citrate reduces serum uric acid levels and improves renal function in hyperuricemic patients treated with the xanthine oxidase inhibitor allopurinol. In: Endocrine Research. 2010 ; Vol. 35, No. 4. pp. 145-154.
@article{927f15b5f1774e019d63143ce9f38480,
title = "The alkalizer citrate reduces serum uric acid levels and improves renal function in hyperuricemic patients treated with the xanthine oxidase inhibitor allopurinol",
abstract = "Objective. Hyperuricemia, an integral component of metabolic syndrome, is a major health problem causing gout and renal damage. Urine alkalizers such as citrate preparations facilitate renal excretion of the uric acid, but its supportive effect on xanthine oxidase inhibitors has not been tested yet. We performed a randomized, prospective study of the effect of a combination of allopurinol and a citrate preparation on renal function in patients with hyperuricemia, employing 70 patients who had hyperuricemia with serum uric acid levels ≥7.0 mgdL, or those diagnosed as having hyperuricemia in the past. Methods. They were randomly enrolled into two study groups: the allopurinol monotherapy (MT) group or combination treatment (CT) group with allopurinol and a citrate preparation. Allopurinol (100200 mgday) in the absence or presence of a citrate preparation (3 gday) was administered for 12 weeks and levels of serum uric acid, its urinary clearance (Cua), and the renal glomerular filtration rates assessed with the creatinine clearance (Ccr) were evaluated before and after the treatment. Results. Serum levels of uric acid decreased significantly in both groups, whereas the change observed was much greater in CT group. Cua was significantly increased in CT group but not in MT group. Ccr was not altered in both groups in general, whereas it was significantly increased in a fraction of CT group with decreased renal function. Conclusions. These results indicate that an additional use of citrate preparations with xanthine oxidase inhibitors is beneficial for patients with hyperuricemia, reducing circulating uric acid and improving their glomerular filtration rates.",
keywords = "Allopurinol, Citrate preparation, Creatinine clearance, Hyperuricemia, Renal function",
author = "Jun Saito and Yoko Matsuzawa and Hiroko Ito and Masao Omura and Yuzuru Ito and Koichiro Yoshimura and Yuki Yajima and Tomoshige Kino and Tetsuo Nishikawa",
year = "2010",
month = "11",
doi = "10.3109/07435800.2010.497178",
language = "English",
volume = "35",
pages = "145--154",
journal = "Endocrine Research",
issn = "0743-5800",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - The alkalizer citrate reduces serum uric acid levels and improves renal function in hyperuricemic patients treated with the xanthine oxidase inhibitor allopurinol

AU - Saito, Jun

AU - Matsuzawa, Yoko

AU - Ito, Hiroko

AU - Omura, Masao

AU - Ito, Yuzuru

AU - Yoshimura, Koichiro

AU - Yajima, Yuki

AU - Kino, Tomoshige

AU - Nishikawa, Tetsuo

PY - 2010/11

Y1 - 2010/11

N2 - Objective. Hyperuricemia, an integral component of metabolic syndrome, is a major health problem causing gout and renal damage. Urine alkalizers such as citrate preparations facilitate renal excretion of the uric acid, but its supportive effect on xanthine oxidase inhibitors has not been tested yet. We performed a randomized, prospective study of the effect of a combination of allopurinol and a citrate preparation on renal function in patients with hyperuricemia, employing 70 patients who had hyperuricemia with serum uric acid levels ≥7.0 mgdL, or those diagnosed as having hyperuricemia in the past. Methods. They were randomly enrolled into two study groups: the allopurinol monotherapy (MT) group or combination treatment (CT) group with allopurinol and a citrate preparation. Allopurinol (100200 mgday) in the absence or presence of a citrate preparation (3 gday) was administered for 12 weeks and levels of serum uric acid, its urinary clearance (Cua), and the renal glomerular filtration rates assessed with the creatinine clearance (Ccr) were evaluated before and after the treatment. Results. Serum levels of uric acid decreased significantly in both groups, whereas the change observed was much greater in CT group. Cua was significantly increased in CT group but not in MT group. Ccr was not altered in both groups in general, whereas it was significantly increased in a fraction of CT group with decreased renal function. Conclusions. These results indicate that an additional use of citrate preparations with xanthine oxidase inhibitors is beneficial for patients with hyperuricemia, reducing circulating uric acid and improving their glomerular filtration rates.

AB - Objective. Hyperuricemia, an integral component of metabolic syndrome, is a major health problem causing gout and renal damage. Urine alkalizers such as citrate preparations facilitate renal excretion of the uric acid, but its supportive effect on xanthine oxidase inhibitors has not been tested yet. We performed a randomized, prospective study of the effect of a combination of allopurinol and a citrate preparation on renal function in patients with hyperuricemia, employing 70 patients who had hyperuricemia with serum uric acid levels ≥7.0 mgdL, or those diagnosed as having hyperuricemia in the past. Methods. They were randomly enrolled into two study groups: the allopurinol monotherapy (MT) group or combination treatment (CT) group with allopurinol and a citrate preparation. Allopurinol (100200 mgday) in the absence or presence of a citrate preparation (3 gday) was administered for 12 weeks and levels of serum uric acid, its urinary clearance (Cua), and the renal glomerular filtration rates assessed with the creatinine clearance (Ccr) were evaluated before and after the treatment. Results. Serum levels of uric acid decreased significantly in both groups, whereas the change observed was much greater in CT group. Cua was significantly increased in CT group but not in MT group. Ccr was not altered in both groups in general, whereas it was significantly increased in a fraction of CT group with decreased renal function. Conclusions. These results indicate that an additional use of citrate preparations with xanthine oxidase inhibitors is beneficial for patients with hyperuricemia, reducing circulating uric acid and improving their glomerular filtration rates.

KW - Allopurinol

KW - Citrate preparation

KW - Creatinine clearance

KW - Hyperuricemia

KW - Renal function

UR - http://www.scopus.com/inward/record.url?scp=77958460141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958460141&partnerID=8YFLogxK

U2 - 10.3109/07435800.2010.497178

DO - 10.3109/07435800.2010.497178

M3 - Article

C2 - 20958145

AN - SCOPUS:77958460141

VL - 35

SP - 145

EP - 154

JO - Endocrine Research

JF - Endocrine Research

SN - 0743-5800

IS - 4

ER -